Abstract
Characterized by the gradual loss of physiological integrity, impaired function, and increased susceptibility to death, aging is considered the primary risk factor for major human diseases, such as cancer, diabetes, cardiovascular disorders, and neurodegenerative diseases. The time-dependent accumulation of cellular damage is widely considered the general cause of aging. While the mechanism of normal aging is still unresolved, researchers have identified different markers of aging, including genomic instability, telomere attrition, epigenetic alterations, loss of proteostasis, deregulated nutrient-sensing, mitochondrial dysfunction, cellular senescence, stem cell exhaustion, and altered intercellular communication. Theories of aging can be divided into two categories: (1) aging is a genetically programmed process, and (2) aging is a random process caused by gradual damage to the organism over time as a result of its vital activities. Aging affects the entire human body, and aging of the brain is undoubtedly different from all other organs, as neurons are highly differentiated postmitotic cells, and the lifespan of most neurons in the postnatal period is equal to the lifespan of the brain. In this chapter, we discuss the conserved mechanisms of aging that may underlie the changes observed in the aging brain, with a focus on mitochondrial function and oxidative stress, autophagy and protein turnover, insulin/IGF signaling, target of rapamycin (TOR) signaling, and sirtuin function.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Lopez-Otin C, Blasco MA, Partridge L, Serrano M, Kroemer G (2013) The hallmarks of aging. Cell 153(6):1194–1217
Isaev NK, Stelmashook EV, Genrikhs EE (2019) Neurogenesis and brain aging. Rev Neurosci 30(6):573–580
Isaev NK, Stelmashook EV, Stelmashook NN, Sharonova IN, Skrebitsky VG (2013) Brain aging and mitochondria-targeted plastoquinone antioxidants of SkQ-type. Biochemistry (Mosc) 78(3):295–300
Worman HJ (2012) Nuclear lamins and laminopathies. J Pathol 226(2):316–325
Lodato MA, Rodin RE, Bohrson CL, Coulter ME, Barton AR, Kwon M et al (2018) Aging and neurodegeneration are associated with increased mutations in single human neurons. Science 359(6375):555–559
Khrapko K, Bodyak N, Thilly WG, van Orsouw NJ, Zhang X, Coller HA et al (1999) Cell-by-cell scanning of whole mitochondrial genomes in aged human heart reveals a significant fraction of myocytes with clonally expanded deletions. Nucleic Acids Res 27(11):2434–2441
Ameur A, Stewart JB, Freyer C, Hagstrom E, Ingman M, Larsson NG et al (2011) Ultra-deep sequencing of mouse mitochondrial DNA: mutational patterns and their origins. PLoS Genet 7(3):e1002028
Payne BAI, Wilson IJ, Hateley CA, Horvath R, Santibanez-Koref M, Samuels DC et al (2011) Mitochondrial aging is accelerated by anti-retroviral therapy through the clonal expansion of mtDNA mutations. Nat Genet 43(8):806–810
Wallace DC (2005) A mitochondrial paradigm of metabolic and degenerative diseases, aging, and cancer: a dawn for evolutionary medicine. Annu Rev Genet 39:359–407
Kujoth GC, Hiona A, Pugh TD, Someya S, Panzer K, Wohlgemuth SE et al (2005) Mitochondrial DNA mutations, oxidative stress, and apoptosis in mammalian aging. Science 309(5733):481–484
Vermulst M, Wanagat J, Kujoth GC, Bielas JH, Rabinovitch PS, Prolla TA et al (2008) DNA deletions and clonal mutations drive premature aging in mitochondrial mutator mice. Nat Genet 40(4):392–394
Hiona A, Sanz A, Kujoth GC, Pamplona R, Seo AY, Hofer T et al (2010) Mitochondrial DNA mutations induce mitochondrial dysfunction, apoptosis and sarcopenia in skeletal muscle of mitochondrial DNA mutator mice. PLoS One 5(7):e11468
Harries LW, Hernandez D, Henley W, Wood AR, Holly AC, Bradley-Smith RM et al (2011) Human aging is characterized by focused changes in gene expression and deregulation of alternative splicing. Aging Cell 10(5):868–878
Nicholas A, de Magalhaes JP, Kraytsberg Y, Richfield EK, Levanon EY, Khrapko K (2010) Age-related gene-specific changes of A-to-I mRNA editing in the human brain. Mech Ageing Dev 131(6):445–447
de Magalhães JP, Curado J, Church GM (2009) Meta-analysis of age-related gene expression profiles identifies common signatures of aging. Bioinformatics (Oxford, England) 25(7):875–881
Finch CE, Morgan DG (1990) RNA and protein metabolism in the aging brain. Annu Rev Neurosci 13:75–88
Strehler BL (1986) Genetic instability as the primary cause of human aging. Exp Gerontol 21(4-5):283–319
Earls LR, Fricke RG, Yu J, Berry RB, Baldwin LT, Zakharenko SS (2012) Age-dependent microRNA control of synaptic plasticity in 22q11 deletion syndrome and schizophrenia. J Neurosci 32(41):14132–14144
Earls LR, Westmoreland JJ, Zakharenko SS (2014) Non-coding RNA regulation of synaptic plasticity and memory: implications for aging. Ageing Res Rev 17:34–42
Aunan JR, Watson MM, Hagland HR, Soreide K (2016) Molecular and biological hallmarks of ageing. Br J Surg 103(2):e29–e46
Butterfield DA, Halliwell B (2019) Oxidative stress, dysfunctional glucose metabolism and Alzheimer disease. Nat Rev Neurosci 20(3):148–160
Koga H, Kaushik S, Cuervo AM (2011) Protein homeostasis and aging: the importance of exquisite quality control. Ageing Res Rev 10(2):205–215
Labbadia J, Morimoto RI (2015) The biology of proteostasis in aging and disease. Annu Rev Biochem 84:435–464
Nixon RA (2017) Amyloid precursor protein and endosomal-lysosomal dysfunction in Alzheimer's disease: inseparable partners in a multifactorial disease. FASEB J 31(7):2729–2743
Morimoto RI, Cuervo AM (2014) Proteostasis and the aging proteome in health and disease. J Gerontol A Biol Sci Med Sci 69(Suppl 1):S33–S38
Pyo J-O, Yoo S-M, Ahn H-H, Nah J, Hong S-H, Kam T-I et al (2013) Overexpression of Atg5 in mice activates autophagy and extends lifespan. Nat Commun 4:2300–2300
Madeo F, Zimmermann A, Maiuri MC, Kroemer G (2015) Essential role for autophagy in life span extension. J Clin Invest 125(1):85–93
Kaushik S, Cuervo AM (2015) Proteostasis and aging. Nat Med 21(12):1406–1415
Di Domenico F, Head E, Butterfield DA, Perluigi M (2014) Oxidative stress and Proteostasis network: culprit and casualty of Alzheimer’s-like neurodegeneration. Adv Geriatr 2014:1–14
Bulteau AL, Szweda LI, Friguet B (2002) Age-dependent declines in proteasome activity in the heart. Arch Biochem Biophys 397(2):298–304
Korovila I, Hugo M, Castro JP, Weber D, Höhn A, Grune T et al (2017) Proteostasis, oxidative stress and aging. Redox Biol 13:550–567
König J, Ott C, Hugo M, Jung T, Bulteau A-L, Grune T et al (2017) Mitochondrial contribution to lipofuscin formation. Redox Biol 11:673–681
Kim YE, Hipp MS, Bracher A, Hayer-Hartl M, Hartl FU (2013) Molecular chaperone functions in protein folding and proteostasis. Annu Rev Biochem 82:323–355
Morrow G, Samson M, Michaud S, Tanguay RM (2004) Overexpression of the small mitochondrial Hsp22 extends drosophila life span and increases resistance to oxidative stress. FASEB J 18(3):598–599
Swindell WR, Masternak MM, Kopchick JJ, Conover CA, Bartke A, Miller RA (2009) Endocrine regulation of heat shock protein mRNA levels in long-lived dwarf mice. Mech Ageing Dev 130(6):393–400
Blake MJ, Udelsman R, Feulner GJ, Norton DD, Holbrook NJ (1991) Stress-induced heat shock protein 70 expression in adrenal cortex: an adrenocorticotropic hormone-sensitive, age-dependent response. Proc Natl Acad Sci U S A 88(21):9873–9877
Carnemolla A, Labbadia JP, Lazell H, Neueder A, Moussaoui S, Bates GP (2014) Contesting the dogma of an age-related heat shock response impairment: implications for cardiac-specific age-related disorders. Hum Mol Genet 23(14):3641–3656
Westerheide SD, Anckar J, Stevens SM Jr, Sistonen L, Morimoto RI (2009) Stress-inducible regulation of heat shock factor 1 by the deacetylase SIRT1. Science (New York, N.Y.) 323(5917):1063–1066
Brehme M, Voisine C, Rolland T, Wachi S, Soper JH, Zhu Y et al (2014) A chaperome subnetwork safeguards proteostasis in aging and neurodegenerative disease. Cell Rep 9(3):1135–1150
Naidoo N (2009) ER and aging-protein folding and the ER stress response. Ageing Res Rev 8(3):150–159
Kaufman RJ (2002) Orchestrating the unfolded protein response in health and disease. J Clin Invest 110(10):1389–1398
Kaufman RJ (1999) Stress signaling from the lumen of the endoplasmic reticulum: coordination of gene transcriptional and translational controls. Genes Dev 13(10):1211–1233
Hampton RY (2000) ER stress response: getting the UPR hand on misfolded proteins. Curr Biol 10(14):R518–R521
Prostko CR, Brostrom MA, Brostrom CO (1993) Reversible phosphorylation of eukaryotic initiation factor 2 alpha in response to endoplasmic reticular signaling. Mol Cell Biochem 127–128:255–265
Xu C, Bailly-Maitre B, Reed JC (2005) Endoplasmic reticulum stress: cell life and death decisions. J Clin Invest 115(10):2656–2664
Szegezdi E, Logue SE, Gorman AM, Samali A (2006) Mediators of endoplasmic reticulum stress-induced apoptosis. EMBO Rep 7(9):880–885
Naidoo N, Ferber M, Master M, Zhu Y, Pack AI (2008) Aging impairs the unfolded protein response to sleep deprivation and leads to proapoptotic signaling. J Neurosci 28(26):6539–6548
Paz Gavilan M, Vela J, Castano A, Ramos B, del Rio JC, Vitorica J et al (2006) Cellular environment facilitates protein accumulation in aged rat hippocampus. Neurobiol Aging 27(7):973–982
Sontag EM, Vonk WIM, Frydman J (2014) Sorting out the trash: the spatial nature of eukaryotic protein quality control. Curr Opin Cell Biol 26:139–146
McConnell KW, Fox AC, Clark AT, Chang N-YN, Dominguez JA, Farris AB et al (2011) The role of heat shock protein 70 in mediating age-dependent mortality in sepsis. J Immunol (Baltimore, Md: 1950) 186(6):3718–3725
Tong BC, Wu AJ, Li M, Cheung KH (2018) Calcium signaling in Alzheimer's disease & therapies. Biochim Biophys Acta Mol Cell Res 1865(11 Pt B):1745–1760
Mattson MP (2010) ER calcium and Alzheimer's disease: in a state of flux. Sci Signal 3(114):pe10
Popugaeva E, Bezprozvanny I (2013) Role of endoplasmic reticulum Ca2+ signaling in the pathogenesis of Alzheimer disease. Front Mol Neurosci 6:29–29
Raza M, Deshpande LS, Blair RE, Carter DS, Sombati S, DeLorenzo RJ (2007) Aging is associated with elevated intracellular calcium levels and altered calcium homeostatic mechanisms in hippocampal neurons. Neurosci Lett 418(1):77–81
Thibault O, Gant JC, Landfield PW (2007) Expansion of the calcium hypothesis of brain aging and Alzheimer's disease: minding the store. Aging Cell 6(3):307–317
Ris L, Godaux E (2007) Synapse specificity of long-term potentiation breaks down with aging. Learn Mem 14(3):185–189
Gant JC, Sama MM, Landfield PW, Thibault O (2006) Early and simultaneous emergence of multiple hippocampal biomarkers of aging is mediated by Ca2+−induced Ca2+ release. J Neurosci 26(13):3482–3490
Thibault O, Landfield PW (1996) Increase in single L-type calcium channels in hippocampal neurons during aging. Science 272(5264):1017–1020
Navakkode S, Liu C, Soong TW (2018) Altered function of neuronal L-type calcium channels in ageing and neuroinflammation: implications in age-related synaptic dysfunction and cognitive decline. Ageing Res Rev 42:86–99
Landfield PW, Pitler TA (1984) Prolonged Ca2+−dependent afterhyperpolarizations in hippocampal neurons of aged rats. Science 226(4678):1089–1092
Toescu EC, Verkhratsky A, Landfield PW (2004) Ca2+ regulation and gene expression in normal brain aging. Trends Neurosci 27(10):614–620
Burke SN, Barnes CA (2010) Senescent synapses and hippocampal circuit dynamics. Trends Neurosci 33(3):153–161
Kumar A, Foster TC (2005) Intracellular calcium stores contribute to increased susceptibility to LTD induction during aging. Brain Res 1031(1):125–128
Norris CM, Halpain S, Foster TC (1998) Reversal of age-related alterations in synaptic plasticity by blockade of L-type Ca2+ channels. J Neurosci 18(9):3171–3179
Rose GM, Ong VS, Woodruff-Pak DS (2007) Efficacy of MEM 1003, a novel calcium channel blocker, in delay and trace eyeblink conditioning in older rabbits. Neurobiol Aging 28(5):766–773
Zoladz PR, Campbell AM, Park CR, Schaefer D, Danysz W, Diamond DM (2006) Enhancement of long-term spatial memory in adult rats by the noncompetitive NMDA receptor antagonists, memantine and neramexane. Pharmacol Biochem Behav 85(2):298–306
Foster TC, Norris CM (1997) Age-associated changes in ca(2+)-dependent processes: relation to hippocampal synaptic plasticity. Hippocampus 7(6):602–612
Bear MF, Cooper LN, Ebner FF (1987) A physiological basis for a theory of synapse modification. Science 237(4810):42–48
Nixon RA (2007) Autophagy, amyloidogenesis and Alzheimer disease. J Cell Sci 120(23):4081
Wolfe DM, Lee J-H, Kumar A, Lee S, Orenstein SJ, Nixon RA (2013) Autophagy failure in Alzheimer's disease and the role of defective lysosomal acidification. Eur J Neurosci 37(12):1949–1961
Soyombo AA, Tjon-Kon-Sang S, Rbaibi Y, Bashllari E, Bisceglia J, Muallem S et al (2006) TRP-ML1 regulates lysosomal pH and acidic lysosomal lipid hydrolytic activity. J Biol Chem 281(11):7294–7301
Curcio-Morelli C, Charles FA, Micsenyi MC, Cao Y, Venugopal B, Browning MF et al (2010) Macroautophagy is defective in mucolipin-1-deficient mouse neurons. Neurobiol Dis 40(2):370–377
Vergarajauregui S, Connelly PS, Daniels MP, Puertollano R (2008) Autophagic dysfunction in mucolipidosis type IV patients. Hum Mol Genet 17(17):2723–2737
Pitt SJ, Funnell TM, Sitsapesan M, Venturi E, Rietdorf K, Ruas M et al (2010) TPC2 is a novel NAADP-sensitive Ca2+ release channel, operating as a dual sensor of luminal pH and Ca2+. J Biol Chem 285(45):35039–35046
Bezprozvanny I (2009) Calcium signaling and neurodegenerative diseases. Trends Mol Med 15(3):89–100
Mattson MP, Cheng B, Davis D, Bryant K, Lieberburg I, Rydel RE (1992) Beta-amyloid peptides destabilize calcium homeostasis and render human cortical neurons vulnerable to excitotoxicity. J Neurosci 12(2):376–389
Demuro A, Mina E, Kayed R, Milton SC, Parker I, Glabe CG (2005) Calcium dysregulation and membrane disruption as a ubiquitous neurotoxic mechanism of soluble amyloid oligomers. J Biol Chem 280(17):17294–17300
Bezprozvanny I, Mattson MP (2008) Neuronal calcium mishandling and the pathogenesis of Alzheimer's disease. Trends Neurosci 31(9):454–463
Ando S (2012) Neuronal dysfunction with aging and its amelioration. Proc Jpn Acad B Phys Biol Sci 88(6):266–282
Ando S, Tanaka Y (1990) Synaptic membrane aging in the central nervous system. Gerontology 36(Suppl 1):10–14
Gibson GE, Peterson C (1981) Aging decreases oxidative metabolism and the release and synthesis of acetylcholine. J Neurochem 37(4):978–984
Tanaka Y, Hasegawa A, Ando S (1996) Impaired synaptic functions with aging as characterized by decreased calcium influx and acetylcholine release. J Neurosci Res 43(1):63–76
Tanaka Y, Ando S (2001) Age-related changes in the subtypes of voltage-dependent calcium channels in rat brain cortical synapses. Neurosci Res 39(2):213–220
Tanaka Y, Ando S (1990) Synaptic aging as revealed by changes in membrane potential and decreased activity of Na+, K(+)-ATPase. Brain Res 506(1):46–52
Marcus MM, Apell HJ, Roudna M, Schwendener RA, Weder HG, Lauger P (1986) (Na+ + K+)-ATPase in artificial lipid vesicles: influence of lipid structure on pumping rate. Biochim Biophys Acta 854(2):270–278
Saito S, Kobayashi S, Ohashi Y, Igarashi M, Komiya Y, Ando S (1994) Decreased synaptic density in aged brains and its prevention by rearing under enriched environment as revealed by synaptophysin contents. J Neurosci Res 39(1):57–62
Carlsson A, Winblad B (1976) Influence of age and time interval between death and autopsy on dopamine and 3-methoxytyramine levels in human basal ganglia. J Neural Transm 38(3-4):271–276
Garnett ES, Firnau G, Nahmias C (1983) Dopamine visualized in the basal ganglia of living man. Nature 305(5930):137–138
Kaasinen V, Rinne JO (2002) Functional imaging studies of dopamine system and cognition in normal aging and Parkinson's disease. Neurosci Biobehav Rev 26(7):785–793
Suhara T, Fukuda H, Inoue O, Itoh T, Suzuki K, Yamasaki T et al (1991) Age-related changes in human D1 dopamine receptors measured by positron emission tomography. Psychopharmacology 103(1):41–45
Wang Y, Chan GL, Holden JE, Dobko T, Mak E, Schulzer M et al (1998) Age-dependent decline of dopamine D1 receptors in human brain: a PET study. Synapse 30(1):56–61
Rinne JO, Hietala J, Ruotsalainen U, Sako E, Laihinen A, Nagren K et al (1993) Decrease in human striatal dopamine D2 receptor density with age: a PET study with [11C]raclopride. J Cereb Blood Flow Metab 13(2):310–314
Rinne JO, Sahlberg N, Ruottinen H, Nagren K, Lehikoinen P (1998) Striatal uptake of the dopamine reuptake ligand [11C]beta-CFT is reduced in Alzheimer's disease assessed by positron emission tomography. Neurology 50(1):152–156
Volkow ND, Fowler JS, Wang GJ, Logan J, Schlyer D, MacGregor R et al (1994) Decreased dopamine transporters with age in health human subjects. Ann Neurol 36(2):237–239
Lanni C, Govoni S, Lucchelli A, Boselli C (2009) Depression and antidepressants: molecular and cellular aspects. Cell Mol Life Sci 66(18):2985–3008
Sibille E, Su J, Leman S, Le Guisquet AM, Ibarguen-Vargas Y, Joeyen-Waldorf J et al (2007) Lack of serotonin1B receptor expression leads to age-related motor dysfunction, early onset of brain molecular aging and reduced longevity. Mol Psychiatry 12(11):1042–1056, 1975
Michel MC, Beck-Sickinger A, Cox H, Doods HN, Herzog H, Larhammar D et al (1998) XVI. International Union of Pharmacology Recommendations for the nomenclature of neuropeptide Y, peptide YY, and pancreatic polypeptide receptors. Pharmacol Rev 50(1):143
Botelho M, Cavadas C (2015) Neuropeptide Y: an anti-aging player? Trends Neurosci 38(11):701–711
Michalkiewicz M, Knestaut KM, Bytchkova EY, Michalkiewicz T (2003) Hypotension and reduced catecholamines in neuropeptide Y transgenic rats. Hypertension 41(5):1056–1062
Hedden T, Gabrieli JD (2004) Insights into the ageing mind: a view from cognitive neuroscience. Nat Rev Neurosci 5(2):87–96
Redrobe JP, Dumont Y, Herzog H, Quirion R (2004) Characterization of neuropeptide Y, Y(2) receptor knockout mice in two animal models of learning and memory processing. J Mol Neurosci 22(3):159–166
Cha CI, Lee YI, Lee EY, Park KH, Baik SH (1997) Age-related changes of VIP, NPY and somatostatin-immunoreactive neurons in the cerebral cortex of aged rats. Brain Res 753(2):235–244
Kowalski C, Micheau J, Corder R, Gaillard R, Conte-Devolx B (1992) Age-related changes in cortico-releasing factor, somatostatin, neuropeptide Y, methionine enkephalin and beta-endorphin in specific rat brain areas. Brain Res 582(1):38–46
Lanni C, Stanga S, Racchi M, Govoni S (2010) The expanding universe of neurotrophic factors: therapeutic potential in aging and age-associated disorders. Curr Pharm Des 16(6):698–717
Mattson MP, Barger SW, Furukawa K, Bruce AJ, Wyss-Coray T, Mark RJ et al (1997) Cellular signaling roles of TGF beta, TNF alpha and beta APP in brain injury responses and Alzheimer's disease. Brain Res Brain Res Rev 23(1-2):47–61
Ai Y, Markesbery W, Zhang Z, Grondin R, Elseberry D, Gerhardt GA et al (2003) Intraputamenal infusion of GDNF in aged rhesus monkeys: distribution and dopaminergic effects. J Comp Neurol 461(2):250–261
Schecterson LC, Bothwell M (1992) Novel roles for neurotrophins are suggested by BDNF and NT-3 mRNA expression in developing neurons. Neuron 9(3):449–463
Katoh-Semba R, Takeuchi IK, Semba R, Kato K (1997) Distribution of brain-derived neurotrophic factor in rats and its changes with development in the brain. J Neurochem 69(1):34–42
Gooney M, Messaoudi E, Maher FO, Bramham CR, Lynch MA (2004) BDNF-induced LTP in dentate gyrus is impaired with age: analysis of changes in cell signaling events. Neurobiol Aging 25(10):1323–1331
Croll SD, Ip NY, Lindsay RM, Wiegand SJ (1998) Expression of BDNF and trkB as a function of age and cognitive performance. Brain Res 812(1-2):200–208
Pelleymounter MA, Cullen MJ, Baker MB, Gollub M, Wellman C (1996) The effects of intrahippocampal BDNF and NGF on spatial learning in aged long Evans rats. Mol Chem Neuropathol 29(2-3):211–226
Sokoloff L (1992) Chapter 2: the brain as a chemical machine. In: Neuronal-astrocytic interactions - implications for Normal and pathological CNS function. Progress in Brain Research, pp 19–33
Hamberger A, Hyden H (1963) Inverse enzymatic changes in neurons and glia during increased function and hypoxia. J Cell Biol 16(3):521–525
Hyden H, Lange PW (1962) A kinetic study of the neuronglia relationship. J Cell Biol 13(2):233–237
Jones JP, Nicholas HJ, Ramsey RB (1975) Rate of sterol formation by rat brain glia and neurons in vitro and in vivo. J Neurochem 24(1):123–126
Ramsey RB, Jones JP, Naqvi SH, Nicholas HJ (1971) The biosynthesis of cholesterol and other sterols by brain tissue. II. A comparison of in vitro and in vivo methods. Lipids 6(4):225–232
Camandola S, Mattson MP (2017) Brain metabolism in health, aging, and neurodegeneration. EMBO J 36(11):1474–1492
Ding F, Yao J, Rettberg JR, Chen S, Brinton RD (2013) Early decline in glucose transport and metabolism precedes shift to ketogenic system in female aging and Alzheimer's mouse brain: implication for bioenergetic intervention. PLoS One 8(11):e79977
Bowling AC, Mutisya EM, Walker LC, Price DL, Cork LC, Beal MF (1993) Age-dependent impairment of mitochondrial function in primate brain. J Neurochem 60(5):1964–1967
Meier-Ruge W, Iwangoff P, Reichlmeier K, Sandoz P (1980) Neurochemical findings in the aging brain. Adv Biochem Psychopharmacol 23:323–338
Stahon KE, Bastian C, Griffith S, Kidd GJ, Brunet S, Baltan S (2016) Age-related changes in axonal and mitochondrial ultrastructure and function in white matter. J Neurosci 36(39):9990–10001
Bai P, Cantó C, Oudart H, Brunyánszki A, Cen Y, Thomas C et al (2011) PARP-1 inhibition increases mitochondrial metabolism through SIRT1 activation. Cell Metab 13(4):461–468
Pittelli M, Felici R, Pitozzi V, Giovannelli L, Bigagli E, Cialdai F et al (2011) Pharmacological effects of exogenous NAD on mitochondrial bioenergetics, DNA repair, and apoptosis. Mol Pharmacol 80(6):1136–1146
Zhu X-H, Lu M, Lee B-Y, Ugurbil K, Chen W (2015) In vivo NAD assay reveals the intracellular NAD contents and redox state in healthy human brain and their age dependences. Proc Natl Acad Sci U S A 112(9):2876–2881
de Leon MJ, Ferris SH, George AE, Reisberg B, Christman DR, Kricheff II et al (1983) Computed tomography and positron emission transaxial tomography evaluations of normal aging and Alzheimer's disease. J Cereb Blood Flow Metab 3(3):391–394
Mosconi L, De Santi S, Li J, Tsui WH, Li Y, Boppana M et al (2008) Hippocampal hypometabolism predicts cognitive decline from normal aging. Neurobiol Aging 29(5):676–692
Small GW, Ercoli LM, Silverman DH, Huang SC, Komo S, Bookheimer SY et al (2000) Cerebral metabolic and cognitive decline in persons at genetic risk for Alzheimer's disease. Proc Natl Acad Sci U S A 97(11):6037–6042
Zuendorf G, Kerrouche N, Herholz K, Baron JC (2003) Efficient principal component analysis for multivariate 3D voxel-based mapping of brain functional imaging data sets as applied to FDG-PET and normal aging. Hum Brain Mapp 18(1):13–21
Kuhl DE, Metter EJ, Riege WH, Hawkins RA (1984) The effect of normal aging on patterns of local cerebral glucose utilization. Ann Neurol 15(Suppl):S133–S137
Gage FH, Kelly PA, Björklund A (1984) Regional changes in brain glucose metabolism reflect cognitive impairments in aged rats. J Neurosci 4(11):2856–2865
Grossman LI, Schmidt TR, Wildman DE, Goodman M (2001) Molecular evolution of aerobic energy metabolism in primates. Mol Phylogenet Evol 18(1):26–36
Haygood R, Fedrigo O, Hanson B, Yokoyama KD, Wray GA (2007) Promoter regions of many neural- and nutrition-related genes have experienced positive selection during human evolution. Nat Genet 39(9):1140–1144
Pontzer H, Brown MH, Raichlen DA, Dunsworth H, Hare B, Walker K et al (2016) Metabolic acceleration and the evolution of human brain size and life history. Nature 533(7603):390–392
Attwell D, Laughlin SB (2001) An energy budget for signaling in the grey matter of the brain. J Cereb Blood Flow Metab 21(10):1133–1145
Harris JJ, Jolivet R, Attwell D (2012) Synaptic energy use and supply. Neuron 75(5):762–777
Rangaraju V, Calloway N, Ryan TA (2014) Activity-driven local ATP synthesis is required for synaptic function. Cell 156(4):825–835
Fabiani M, Low KA, Tan CH, Zimmerman B, Fletcher MA, Schneider-Garces N et al (2014) Taking the pulse of aging: mapping pulse pressure and elasticity in cerebral arteries with optical methods. Psychophysiology 51(11):1072–1088
Schultz SK, O'Leary DS, Boles Ponto LL, Watkins GL, Hichwa RD, Andreasen NC (1999) Age-related changes in regional cerebral blood flow among young to mid-life adults. Neuroreport 10(12):2493–2496
Rosenberg GA (2012) Neurological diseases in relation to the blood-brain barrier. J Cereb Blood Flow Metab 32(7):1139–1151
Zlokovic BV (2011) Neurovascular pathways to neurodegeneration in Alzheimer's disease and other disorders. Nat Rev Neurosci 12(12):723–738
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2023 Springer Nature Singapore Pte Ltd.
About this chapter
Cite this chapter
Li, M., An, H., Wang, W., Wei, D. (2023). Biomolecular Markers of Brain Aging. In: Zhang, Z. (eds) Cognitive Aging and Brain Health. Advances in Experimental Medicine and Biology, vol 1419. Springer, Singapore. https://doi.org/10.1007/978-981-99-1627-6_9
Download citation
DOI: https://doi.org/10.1007/978-981-99-1627-6_9
Published:
Publisher Name: Springer, Singapore
Print ISBN: 978-981-99-1626-9
Online ISBN: 978-981-99-1627-6
eBook Packages: Biomedical and Life SciencesBiomedical and Life Sciences (R0)